Highlights
Acute coronary occlusions without ST elevation criteria suffer double mortality without reperfusion.
ECG findings other than ST elevation criteria can identify occlusion myocardial infarction sooner and more accurately.
Our results justify further research to evaluate the external validity of advanced ECG interpretation.
BackgroundEfforts to reach UNAIDS’ treatment and viral suppression targets have increased demand for viral load (VL) testing and strained existing laboratory networks, affecting turnaround time. Longer VL turnaround times delay both initiation of formal adherence counseling and switches to second-line therapy for persons failing treatment and contribute to poorer health outcomes.MethodsWe utilized descriptive statistics and logistic regression to analyze VL testing data collected in Malawi between January 2013 and March 2016. The primary outcomes assessed were greater-than-median pretest phase turnaround time (days elapsed from specimen collection to receipt at the laboratory) and greater-than-median test phase turnaround time (days from receipt to testing).ResultsThe median number of days between specimen collection and testing increased 3-fold between 2013 (8 days, interquartile range (IQR) = 6–16) and 2015 (24, IQR = 13–39) (p<0.001). Multivariable analysis indicated that the odds of longer pretest phase turnaround time were significantly higher for specimen collection districts without laboratories capable of conducting viral load tests (adjusted odds ratio (aOR) = 5.16; 95% confidence interval (CI) = 5.04–5.27) as well as for Malawi’s Northern and Southern regions. Longer test phase turnaround time was significantly associated with use of dried blood spots instead of plasma (aOR = 2.30; 95% CI = 2.23–2.37) and for certain testing months and testing laboratories.ConclusionIncreased turnaround time for VL testing appeared to be driven in part by categorical factors specific to the phase of turnaround time assessed. Given the implications of longer turnaround time and the global effort to scale up VL testing, addressing these factors via increasing efficiencies, improving quality management systems and generally strengthening the VL spectrum should be considered essential components of controlling the HIV epidemic.
Objectives: Burns are common injuries that can result in significant scarring, leading to poor function and disfigurement. Unlike mechanical injuries, burns often progress both in depth and in size over the first few days after injury, possibly due to inflammation and oxidative stress. A major gap in the field of burns is the lack of an effective therapy that reduces burn injury progression. Because stem cells have been shown to improve healing in several injury models, the authors hypothesized that species-specific mesenchymal stem cells (MSCs) would reduce injury progression in a rat comb-burn model.Methods: Using a brass comb preheated to 100°C, the authors created four rectangular burns, separated by three unburned interspaces on both sides of the backs of male Sprague-Dawley rats. The interspaces represented the ischemic zones surrounding the central necrotic core. In an attempt to reduce burn injury progression, 20 rats were randomized to tail vein injections of 1 mL of rat-specific MSCs, 10 6 cells/ mL (n = 10), or normal saline (n = 10), 60 minutes after injury.Results: While the authors were unable to identify any quantum dot (Q-dot)-labeled MSCs in the injured skin, at 7 days the mean percentage of the unburned interspaces that became necrotic in the MSC group was significantly less than in the control group (80% vs. 100%, p < 0.0001).Conclusions: Intravenous injection of rat MSCs reduced burn injury progression in a rat comb-burn model.ACADEMIC EMERGENCY MEDICINE 2013; 20:398-402
We evaluated a novel octylcyanoacrylate-based liquid occlusive dressing for partial-thickness wounds. One hundred and fifteen standardized wounds were created with an electric dermatome set at a depth of 600 micro on the flanks of three pigs and randomly treated with liquid occlusive dressing, a hydrocolloid dressing, or gauze. In one pig, wounds were swabbed with Staphylococcus aureus. Biopsies were taken after 4, 5, 6, and 21 days. Hemostasis was obtained in all wounds treated with the liquid occlusive. The percent reepithelialization of wounds treated with the liquid occlusive and hydrocolloid dressings were significantly greater at days 4 and 5 than control wounds (78% and 82% vs. 40%, p < 0.001 and 99% and 100% vs. 72%, p < 0.001, respectively). None of the liquid occlusive-treated wounds challenged with bacteria became infected. Foreign body reactions were least common in wounds treated with the liquid occlusive (p < 0.001). Scar depth was less for liquid occlusive- and hydrocolloid-treated wounds than controls (285 micro and 303 micro vs. 490 micro, p < 0.001). We conclude that excisional wounds treated with the liquid occlusive dressing reepithelialize as quickly as hydrocolloid-treated wounds. The liquid occlusive dressing is an effective microbial barrier and hemostatic agent resulting in fewer foreign body reactions than hydrocolloid-treated wounds or controls.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.